KEMX vs. NVOH
KEMX (KraneShares MSCI Emerging Markets ex China Index ETF) and NVOH (Novo Nordisk A/S (B Shares) ADRhedged ETF) are both Foreign Large Cap Equities funds. KEMX is passively managed, while NVOH is actively managed. Over the past year, KEMX returned 68.58% vs -22.77% for NVOH. At a 0.19 correlation, their price movements are largely independent. KEMX charges 0.25%/yr vs 0.19%/yr for NVOH.
Performance
KEMX vs. NVOH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KEMX achieves a 40.15% return, which is significantly higher than NVOH's -0.97% return.
KEMX
- 1D
- 1.31%
- 1M
- 2.22%
- YTD
- 40.15%
- 6M
- 41.62%
- 1Y
- 68.58%
- 3Y*
- 28.53%
- 5Y*
- 13.57%
- 10Y*
- —
NVOH
- 1D
- 0.00%
- 1M
- 9.60%
- YTD
- -0.97%
- 6M
- -3.24%
- 1Y
- -22.77%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
KEMX vs. NVOH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
KEMX KraneShares MSCI Emerging Markets ex China Index ETF | 40.15% | 34.27% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | -0.97% | -43.79% |
Correlation
The correlation between KEMX and NVOH is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2025 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KEMX vs. NVOH — Risk / Return Rank
KEMX
NVOH
KEMX vs. NVOH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KEMX | NVOH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.20 | ||
| Sortino ratioReturn per unit of downside risk | +3.63 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 0.95 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 4.49 | -0.49 | +4.98 |
| Martin ratioReturn relative to average drawdown | 16.95 | -0.78 | +17.73 |
Loading charts...
Drawdowns
KEMX vs. NVOH - Drawdown Comparison
The maximum KEMX drawdown since its inception was -38.80%, smaller than the maximum NVOH drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for KEMX and NVOH.
Loading charts...
Drawdown Indicators
| KEMX | NVOH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.80% | -61.60% | +22.80% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | -46.22% | +30.86% |
Max Drawdown (3Y)Largest decline over 3 years | -19.62% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -30.85% | — | — |
Current DrawdownCurrent decline from peak | -4.61% | -47.89% | +43.28% |
Average DrawdownAverage peak-to-trough decline | -8.82% | -38.76% | +29.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.06% | 29.21% | -25.15% |
Volatility
KEMX vs. NVOH - Volatility Comparison
KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a higher volatility of 12.89% compared to Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) at 11.15%. This indicates that KEMX's price experiences larger fluctuations and is considered to be riskier than NVOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KEMX | NVOH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.89% | 11.15% | +1.74% |
Volatility (6M)Calculated over the trailing 6-month period | 23.20% | 36.97% | -13.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.17% | 49.38% | -24.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.97% | 48.74% | -29.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.33% | 48.74% | -27.41% |
KEMX vs. NVOH - Expense Ratio Comparison
KEMX has a 0.25% expense ratio, which is higher than NVOH's 0.19% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
KEMX vs. NVOH - Dividend Comparison
KEMX's dividend yield for the trailing twelve months is around 2.34%, less than NVOH's 6.53% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
KEMX KraneShares MSCI Emerging Markets ex China Index ETF | 2.34% | 3.28% | 3.39% | 2.00% | 4.10% | 4.79% | 1.69% | 2.77% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 6.53% | 2.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
KEMX and NVOH have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEMX has higher volatility (12.89%) compared to NVOH (11.15%). In terms of maximum drawdown, KEMX dropped -38.80% vs NVOH's -61.60%.
On 1-year performance, KEMX leads with 68.58% vs -22.77% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, NVOH has been the lower-risk option at 11.15%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, KEMX has performed better with a 68.58% return vs -22.77%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NVOH is cheaper with a 0.19% expense ratio, compared with 0.25% for KEMX.
NVOH has the higher dividend yield at 6.53%, compared with 2.34% for KEMX.
They also come from different issuers: CICC and Precidian. Their fees differ too: 0.25% for KEMX and 0.19% for NVOH.
KEMX currently has the higher Sharpe Ratio (2.74 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KEMX and NVOH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer